Nifty

:

14504.80

Sensex

:

48544.06

194.00 (1.36%)
660.68 (1.38%)

Login

Nifty
Sensex

:
:

14504.80
48544.06

194.00 (1.36%)
660.68 (1.38%)

Sequent Scientific Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

67/99

BSE: 512529 | NSE: SEQUENT

Watchlist

NSE BSE

245.15

12-Apr-2021

Open
High
Low
Previous Close

263.00
267.00
243.80
267.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1009003
2558.98
279.00
69.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,090.06
63.27
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,344.88
N/A
7.73

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.22
13.54
4.59

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.11
24.60
8.84

PAT CAGR (%)

10 Years
5 Years
3 Years

2.97
15.48
-45.06

P:E (Median)

8 Years
5 Years
3 Years

-
21.91
30.73

P:BV (Average)

8 Years
5 Years
3 Years

7.53
3.27
3.36

EV:EBITDA (Average)

8 Years
5 Years
3 Years

57.94
25.65
16.61

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 70.57 61.80 14.19% 69.64 51.52 35.17% 59.24 51.72 14.54% 62.29 55.59 12.05%
Expenses 57.34 55.94 2.50% 59.17 48.72 21.45% 49.46 48.68 1.60% 51.76 53.11 -2.54%
EBITDA 13.24 5.86 125.94% 10.47 2.80 273.93% 9.79 3.04 222.04% 10.54 2.48 325.00%
EBIDTM 18.76% 9.49% 15.03% 5.43% 16.52% 5.87% -0.29% 4.46%
Other Income 5.67 2.22 155.41% 6.10 7.26 -15.98% 2.27 2.03 11.82% 3.05 1.61 89.44%
Interest 0.60 1.19 -49.58% 0.73 1.19 -38.66% 1.10 1.42 -22.54% 1.23 1.83 -32.79%
Depreciation 2.19 2.19 0.00% 2.16 2.23 -3.14% 2.16 2.23 -3.14% 2.31 2.26 2.21%
PBT 16.11 4.69 243.50% 11.03 6.64 66.11% 8.80 1.42 519.72% 10.06 0.01 100,500.00%
Tax 3.94 1.77 122.60% 1.82 -3.54 - 1.87 0.00 0 3.24 -1.38 -
PAT 12.17 2.92 316.78% 9.21 10.18 -9.53% 6.92 1.42 387.32% 6.82 1.39 390.65%
PATM 17.24% 4.72% 13.23% 19.77% 11.69% 2.75% 2.87% 2.50%
EPS 0.49 0.12 308.33% 0.37 0.41 -9.76% 0.28 0.06 366.67% 0.27 0.06 350.00%

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 358.21 316.42 13.21% 346.27 284.22 21.83% 310.26 278.02 11.60% 300.58 281.90 6.63%
Expenses 291.91 266.44 9.56% 289.88 247.06 17.33% 259.25 239.57 8.21% 255.85 242.91 5.33%
EBITDA 66.31 49.98 32.67% 56.39 37.16 51.75% 51.02 38.44 32.73% 44.74 39.00 14.72%
EBIDTM 18.51% 15.80% 16.29% 13.07% 16.44% 13.83% 14.01% 13.83%
Other Income 2.81 0.98 186.73% 2.64 5.97 -55.78% 1.55 1.31 18.32% 1.83 2.43 -24.69%
Interest 6.20 9.60 -35.42% 7.36 7.84 -6.12% 7.65 8.95 -14.53% 9.33 8.90 4.83%
Depreciation 11.58 13.05 -11.26% 13.30 12.46 6.74% 13.03 12.01 8.49% 13.09 10.92 19.87%
PBT 51.33 28.31 81.31% 29.32 22.83 28.43% 31.89 18.80 69.63% 24.14 21.60 11.76%
Tax 11.64 4.25 173.88% 7.96 -1.64 - 7.42 3.50 112.00% 5.91 0.28 2,010.71%
PAT 39.69 24.06 64.96% 21.36 24.47 -12.71% 24.47 15.30 59.93% 18.23 21.32 -14.49%
PATM 11.08% 7.60% 6.17% 8.61% 7.89% 5.50% 7.11% 7.56%
EPS 1.50 0.82 82.93% 0.86 0.86 0.00% 0.84 0.46 82.61% 28.29 0.69 4,000.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 261.74 227.33 166.26 271.20 105.87 394.59 444.82 445.08 235.77 332.43 277.98 Net Sales Growth 18.63% 36.73% -38.69% 156.16% -73.17% -11.29% -0.06% 88.78% -29.08% 19.59% Cost Of Goods Sold 579.93 113.04 94.62 161.37 72.47 218.33 229.86 245.55 133.20 190.11 140.26 Gross Profit -318.19 114.29 71.64 109.83 33.40 176.26 214.95 199.53 102.57 142.32 137.72 GP Margin -121.57% 50.27% 43.09% 40.50% 31.55% 44.67% 48.32% 44.83% 43.50% 42.81% 49.54% Total Expenditure 217.73 205.10 163.57 258.06 121.27 359.06 384.54 437.81 253.85 296.96 231.01 Power & Fuel Cost - 12.73 8.52 2.32 2.14 17.98 20.68 21.77 17.98 20.21 15.68 % Of Sales - 5.60% 5.12% 0.86% 2.02% 4.56% 4.65% 4.89% 7.63% 6.08% 5.64% Employee Cost - 17.10 10.71 25.12 17.90 38.84 45.47 42.87 29.10 25.44 22.70 % Of Sales - 7.52% 6.44% 9.26% 16.91% 9.84% 10.22% 9.63% 12.34% 7.65% 8.17% Manufacturing Exp. - 51.52 41.13 15.87 14.85 56.50 48.54 49.63 34.33 26.30 28.23 % Of Sales - 22.66% 24.74% 5.85% 14.03% 14.32% 10.91% 11.15% 14.56% 7.91% 10.16% General & Admin Exp. - 8.55 7.15 13.02 9.92 15.19 23.99 41.71 14.93 10.56 16.58 % Of Sales - 3.76% 4.30% 4.80% 9.37% 3.85% 5.39% 9.37% 6.33% 3.18% 5.96% Selling & Distn. Exp. - 2.11 1.04 0.83 0.47 4.03 5.71 7.90 7.03 9.12 7.21 % Of Sales - 0.93% 0.63% 0.31% 0.44% 1.02% 1.28% 1.77% 2.98% 2.74% 2.59% Miscellaneous Exp. - 0.04 0.40 39.53 3.53 8.19 10.29 28.37 17.28 15.22 7.21 % Of Sales - 0.02% 0.24% 14.58% 3.33% 2.08% 2.31% 6.37% 7.33% 4.58% 0.12% EBITDA 44.04 22.23 2.69 13.14 -15.40 35.53 60.28 7.27 -18.08 35.47 46.97 EBITDA Margin 16.83% 9.78% 1.62% 4.85% -14.55% 9.00% 13.55% 1.63% -7.67% 10.67% 16.90% Other Income 17.09 14.56 13.96 24.67 19.07 15.55 3.56 5.25 2.92 11.33 11.41 Interest 3.66 5.04 3.22 4.54 0.42 16.44 47.46 38.74 24.64 28.27 20.04 Depreciation 8.82 8.95 7.22 14.37 3.25 24.18 26.38 27.13 23.00 21.03 17.18 PBT 46.00 22.81 6.20 18.90 -0.01 10.46 -9.99 -53.34 -62.81 -2.50 21.16 Tax 10.87 1.47 -1.38 2.87 0.00 0.07 1.70 0.00 -8.31 -3.96 6.28 Tax Rate 23.63% 6.44% -22.26% 0.70% 0.00% 0.67% 3.95% 0.00% 13.23% 158.40% 28.28% PAT 35.12 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 -54.50 1.47 15.93 PAT before Minority Interest 35.12 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 -54.50 1.47 15.93 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.42% 9.39% 4.57% 149.86% -0.01% 2.63% 9.29% -25.71% -23.12% 0.44% 5.73% PAT Growth 120.74% 181.16% -98.13% - - -74.85% - - - -90.77% EPS 1.41 0.86 0.31 16.36 0.00 0.42 1.66 -4.61 -2.19 0.06 0.64

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,315.32 1,179.24 1,039.31 1,030.59 683.57 624.98 465.36 455.46 326.86 345.81 311.89 Net Sales Growth 13.33% 13.46% 0.85% 50.77% 9.37% 34.30% 2.17% 39.34% -5.48% 10.88% Cost Of Goods Sold 5,162.65 605.05 543.01 554.23 356.70 311.71 240.72 243.65 181.72 192.27 162.01 Gross Profit -3,847.33 574.19 496.30 476.36 326.87 313.27 224.65 211.81 145.14 153.53 149.87 GP Margin -292.50% 48.69% 47.75% 46.22% 47.82% 50.12% 48.27% 46.50% 44.40% 44.40% 48.05% Total Expenditure 1,096.89 1,008.92 914.37 919.10 643.03 568.27 444.87 438.68 342.51 308.74 266.39 Power & Fuel Cost - 24.73 23.06 14.66 12.77 26.51 23.32 22.06 23.53 20.21 16.75 % Of Sales - 2.10% 2.22% 1.42% 1.87% 4.24% 5.01% 4.84% 7.20% 5.84% 5.37% Employee Cost - 165.06 145.95 132.07 106.22 88.62 62.39 48.12 41.47 29.40 29.82 % Of Sales - 14.00% 14.04% 12.81% 15.54% 14.18% 13.41% 10.57% 12.69% 8.50% 9.56% Manufacturing Exp. - 83.24 77.73 59.07 57.63 72.14 54.31 52.30 41.42 27.88 33.72 % Of Sales - 7.06% 7.48% 5.73% 8.43% 11.54% 11.67% 11.48% 12.67% 8.06% 10.81% General & Admin Exp. - 56.37 58.35 70.92 48.60 36.44 33.79 43.58 23.96 13.69 15.95 % Of Sales - 4.78% 5.61% 6.88% 7.11% 5.83% 7.26% 9.57% 7.33% 3.96% 5.11% Selling & Distn. Exp. - 45.16 36.29 36.87 28.78 17.46 20.27 12.30 10.51 9.23 7.52 % Of Sales - 3.83% 3.49% 3.58% 4.21% 2.79% 4.36% 2.70% 3.22% 2.67% 2.41% Miscellaneous Exp. - 29.32 29.98 51.29 32.34 15.40 10.07 16.66 19.91 16.05 7.52 % Of Sales - 2.49% 2.88% 4.98% 4.73% 2.46% 2.16% 3.66% 6.09% 4.64% 0.20% EBITDA 218.46 170.32 124.94 111.49 40.54 56.71 20.49 16.78 -15.65 37.07 45.50 EBITDA Margin 16.61% 14.44% 12.02% 10.82% 5.93% 9.07% 4.40% 3.68% -4.79% 10.72% 14.59% Other Income 8.83 10.09 8.67 17.20 11.08 14.30 9.96 3.84 4.96 10.48 6.69 Interest 30.54 35.71 32.80 39.70 28.34 38.56 44.37 39.04 33.45 29.99 23.80 Depreciation 51.00 50.62 41.92 53.30 40.07 46.22 32.94 32.60 28.61 22.98 20.69 PBT 136.68 94.08 58.88 35.70 -16.80 -13.77 -46.85 -51.00 -72.75 -5.41 7.69 Tax 32.93 12.03 2.01 13.46 -0.41 2.62 3.39 0.58 -8.06 -3.95 7.51 Tax Rate 24.09% 12.79% 3.41% 3.03% 2.44% -19.03% -40.50% -0.53% 11.08% 73.01% 215.80% PAT 103.75 69.91 48.66 421.57 -13.83 -18.47 -10.74 -110.49 -64.69 -1.40 -0.17 PAT before Minority Interest 97.64 82.05 56.88 430.83 -16.39 -16.39 -11.76 -110.49 -64.69 -1.46 -4.02 Minority Interest -6.11 -12.14 -8.22 -9.26 2.56 -2.08 1.02 0.00 0.00 0.06 3.85 PAT Margin 7.89% 5.93% 4.68% 40.91% -2.02% -2.96% -2.31% -24.26% -19.79% -0.40% -0.05% PAT Growth 21.84% 43.67% -88.46% - - - - - - - EPS 4.18 2.81 1.96 16.97 -0.56 -0.74 -0.43 -4.45 -2.60 -0.06 -0.01

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 886.22 917.79 948.62 1,257.33 1,205.88 156.92 50.25 109.45 126.71 125.55 Share Capital 49.67 49.37 48.75 48.75 47.65 30.48 26.74 23.44 21.34 21.23 Total Reserves 822.45 849.53 882.29 1,193.03 1,134.19 92.50 11.15 74.13 105.37 104.31 Non-Current Liabilities 11.50 36.20 19.01 38.28 42.08 79.95 109.66 113.91 85.77 111.68 Secured Loans 15.16 20.61 0.00 13.98 23.82 56.70 90.47 107.52 61.38 86.83 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.35 0.56 0.72 0.88 1.04 Long Term Provisions 4.09 22.30 24.39 28.88 22.84 22.97 18.70 5.68 15.27 11.52 Current Liabilities 105.24 79.87 26.69 168.71 109.89 427.45 414.42 319.83 298.94 190.96 Trade Payables 64.34 52.60 24.56 69.96 73.64 69.81 135.38 145.92 122.57 78.41 Other Current Liabilities 9.30 6.01 1.91 35.29 20.85 86.85 31.38 27.75 71.60 33.88 Short Term Borrowings 14.39 19.27 0.00 63.22 15.04 270.29 241.08 139.47 98.09 68.90 Short Term Provisions 17.22 1.99 0.21 0.24 0.36 0.51 6.58 6.70 6.68 9.77 Total Liabilities 1,002.96 1,033.86 994.32 1,464.32 1,357.85 664.32 574.33 543.19 511.42 428.19 Net Block 69.41 52.42 23.68 181.67 169.60 200.88 219.93 205.10 206.29 185.49 Gross Block 99.30 73.33 37.61 230.34 193.00 302.01 338.33 301.32 276.44 235.90 Accumulated Depreciation 29.89 20.90 13.93 48.67 23.40 101.13 118.40 96.22 70.15 50.41 Non Current Assets 879.01 946.46 853.77 1,095.85 1,056.39 421.95 333.95 321.05 293.54 264.65 Capital Work in Progress 3.72 0.03 3.12 32.26 19.97 8.93 11.12 21.51 17.57 16.44 Non Current Investment 738.95 788.16 672.67 834.62 834.87 183.11 65.04 54.57 38.81 13.56 Long Term Loans & Adv. 65.53 83.27 138.79 26.79 23.08 26.30 36.20 38.56 28.57 48.13 Other Non Current Assets 1.39 22.57 15.51 20.52 8.86 2.73 1.66 1.30 2.30 1.02 Current Assets 123.95 87.41 140.54 368.46 301.47 242.38 240.38 222.13 217.89 163.54 Current Investments 18.75 0.10 13.98 62.28 62.29 0.08 0.08 0.18 0.28 0.33 Inventories 31.42 25.33 13.83 62.53 56.19 66.88 101.25 82.67 63.11 61.47 Sundry Debtors 40.79 42.90 78.47 113.03 73.75 98.77 79.66 70.16 82.48 53.01 Cash & Bank 3.72 1.88 3.04 3.06 4.80 27.38 19.13 31.07 15.77 5.78 Other Current Assets 29.27 1.56 1.13 12.88 104.45 49.28 40.26 38.05 56.26 42.95 Short Term Loans & Adv. 25.66 15.65 30.09 114.68 86.38 30.28 36.32 32.06 50.48 41.20 Net Current Assets 18.71 7.54 113.85 199.75 191.58 -185.08 -174.04 -97.69 -81.05 -27.42 Total Assets 1,002.96 1,033.87 994.31 1,464.31 1,357.86 664.33 574.33 543.18 511.43 428.19

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 742.76 706.69 647.58 976.79 945.71 91.27 56.73 95.00 122.53 123.06 Share Capital 49.67 49.37 48.75 48.75 47.65 30.48 26.74 23.44 21.34 21.23 Total Reserves 679.00 638.43 581.25 912.49 874.01 26.85 -0.37 59.68 101.19 101.82 Non-Current Liabilities 241.56 214.75 227.13 246.20 299.72 277.55 159.23 144.35 104.79 123.22 Secured Loans 107.97 126.94 85.14 141.76 197.50 249.97 150.52 137.32 80.19 90.73 Unsecured Loans 42.09 20.90 18.40 23.38 13.82 0.35 0.56 0.72 0.88 8.46 Long Term Provisions 13.16 30.50 28.54 34.76 28.66 25.70 8.03 6.09 15.49 11.74 Current Liabilities 479.57 440.41 430.93 663.55 290.37 406.09 405.28 345.41 329.56 199.21 Trade Payables 220.38 209.35 160.49 203.04 143.94 90.94 114.59 150.91 123.94 82.61 Other Current Liabilities 92.65 87.80 106.52 259.26 83.23 107.43 56.80 35.63 75.38 37.71 Short Term Borrowings 134.36 127.36 152.41 194.70 56.04 204.31 226.60 151.76 123.34 69.09 Short Term Provisions 32.19 15.90 11.51 6.54 7.17 3.42 7.29 7.12 6.89 9.80 Total Liabilities 1,508.63 1,402.10 1,342.62 1,903.76 1,538.02 921.84 625.82 589.34 562.37 446.25 Net Block 632.23 498.14 475.97 684.33 586.48 474.43 237.59 227.26 229.76 210.76 Gross Block 818.12 638.06 581.74 789.60 643.70 596.25 369.07 330.69 305.11 264.26 Accumulated Depreciation 185.89 139.91 105.77 105.27 57.22 121.82 131.48 103.43 75.35 53.50 Non Current Assets 794.52 795.99 804.61 1,176.02 1,047.48 612.00 359.87 358.31 351.94 282.23 Capital Work in Progress 13.42 22.61 18.04 32.55 23.52 39.06 43.04 88.71 64.07 19.53 Non Current Investment 131.29 179.65 221.73 363.97 360.58 58.04 0.04 1.64 0.04 0.05 Long Term Loans & Adv. 14.40 32.27 31.01 37.51 30.35 36.01 76.06 39.28 55.77 50.87 Other Non Current Assets 3.18 63.31 57.86 57.66 46.54 4.47 3.15 1.42 2.30 1.02 Current Assets 714.11 606.12 538.01 727.74 490.54 309.84 265.94 231.04 210.42 164.02 Current Investments 40.18 0.47 17.34 64.12 66.98 0.58 0.08 0.18 0.28 0.33 Inventories 219.42 200.10 158.57 160.81 135.08 94.36 101.40 85.62 68.24 65.55 Sundry Debtors 318.76 278.25 258.35 254.62 192.39 115.44 83.54 65.81 70.41 55.45 Cash & Bank 75.83 72.04 42.45 47.40 25.30 38.46 36.21 33.00 35.88 9.17 Other Current Assets 59.92 8.51 5.25 146.31 70.80 61.01 44.71 46.44 35.62 33.52 Short Term Loans & Adv. 44.41 46.75 56.05 54.48 46.69 41.86 37.47 36.48 28.84 31.25 Net Current Assets 234.54 165.71 107.08 64.19 200.17 -96.25 -139.34 -114.37 -119.13 -35.19 Total Assets 1,508.63 1,402.11 1,342.62 1,903.76 1,538.02 921.84 625.81 589.35 562.36 446.25

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 30.20 73.80 -4.02 -24.04 100.02 -24.99 -42.37 -12.70 10.40 48.77 PBT 22.81 6.20 409.27 -0.01 10.46 43.01 -114.42 -62.81 -2.50 22.21 Adjustment 1.74 -2.19 -392.74 20.30 33.58 22.54 136.20 61.04 42.30 22.10 Changes in Working Capital 7.84 70.32 -21.10 -42.97 56.92 -89.22 -63.80 -11.41 -26.13 10.05 Cash after chg. in Working capital 32.39 74.34 -4.57 -22.68 100.95 -23.68 -42.01 -13.18 13.68 54.37 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.19 -0.54 0.55 -1.36 -0.93 -1.31 -0.35 0.48 -3.28 -5.60 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -10.38 -114.06 15.60 -46.84 -359.41 23.65 -60.82 -31.29 -41.11 -68.34 Net Fixed Assets -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 -28.82 -41.67 -80.90 Net Investments 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 -15.66 -25.20 31.50 Others -11.28 20.18 -416.52 2.53 256.59 103.21 -23.83 13.19 25.76 -18.94 Cash from Financing Activity -18.01 40.34 -11.78 70.97 247.38 7.96 107.56 38.81 31.58 12.85 Net Cash Inflow / Outflow 1.81 0.07 -0.19 0.09 -12.01 6.62 4.37 -5.17 0.87 -6.71 Opening Cash & Equivalents 1.07 1.00 1.19 1.10 13.11 6.48 2.11 7.29 5.78 12.44 Closing Cash & Equivalent 2.87 1.07 1.00 1.19 1.10 13.10 6.48 2.11 7.29 5.78

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 115.33 116.02 45.24 -7.19 -0.05 -23.55 -44.78 -3.82 21.48 49.63 PBT 94.08 58.88 445.79 -16.80 -13.77 -8.37 -109.91 -72.75 -5.41 3.49 Adjustment 91.41 84.47 -313.85 123.31 83.81 35.92 133.52 65.98 46.98 36.77 Changes in Working Capital -58.30 -27.95 -77.87 -104.37 -71.46 -53.98 -67.45 2.48 -17.29 15.96 Cash after chg. in Working capital 127.18 115.40 54.06 2.14 -1.42 -26.44 -43.84 -4.28 24.27 56.22 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -11.85 0.62 -8.83 -9.33 1.37 2.89 -0.95 0.46 -2.79 -6.59 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -72.27 -67.69 7.17 -116.18 -315.83 -154.69 -79.95 -54.89 -66.78 -71.77 Net Fixed Assets -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 -28.82 -41.67 -80.90 Net Investments 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 -15.66 -25.20 31.50 Others -73.17 66.55 -424.95 -66.81 300.17 -75.13 -42.96 -10.41 0.09 -22.37 Cash from Financing Activity -42.75 -20.08 -56.96 147.44 308.69 179.41 145.54 34.70 61.94 16.51 Net Cash Inflow / Outflow 0.31 28.25 -4.55 24.07 -7.19 1.17 20.80 -24.02 16.63 -5.62 Opening Cash & Equivalents 67.79 39.54 44.10 20.03 21.85 22.96 3.45 27.37 9.17 14.07 Closing Cash & Equivalent 68.10 67.79 39.54 44.10 20.03 21.83 22.96 3.45 27.37 9.17

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 35.11 36.41 38.20 50.95 49.61 8.07 2.83 8.33 11.88 11.82 ROA 2.10% 0.75% 33.06% 0.00% 1.03% 6.67% -20.48% -10.34% 0.31% 4.14% ROE 2.41% 0.83% 37.41% 0.00% 1.59% 51.35% -168.93% -48.60% 1.16% 13.16% ROCE 2.96% 0.99% 36.09% 0.03% 3.07% 20.15% -19.54% -10.55% 7.93% 15.27% Fixed Asset Turnover 2.66 3.00 2.05 0.52 1.65 1.45 1.45 0.85 1.35 1.48 Receivable days 66.55 132.93 127.17 310.76 77.04 70.28 58.94 113.28 71.66 62.69 Inventory Days 45.13 42.89 50.71 197.54 54.96 66.23 72.35 108.19 65.88 68.83 Payable days 103.60 86.82 78.05 239.99 74.47 102.24 128.36 197.86 122.93 105.70 Cash Conversion Cycle 8.08 88.99 99.83 268.31 57.53 34.27 2.92 23.61 14.61 25.82 Total Debt/Equity 0.04 0.05 0.00 0.07 0.04 2.77 9.23 2.72 1.75 1.40 Interest Cover 5.53 2.93 91.09 0.97 1.64 1.91 -1.95 -1.55 0.91 2.11

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 29.34 27.86 25.85 39.44 38.69 3.76 1.97 7.09 11.48 11.59 ROA 5.64% 4.14% 26.54% -0.95% -1.33% -1.52% -18.19% -11.23% -0.29% -0.97% ROE 11.58% 8.63% 54.15% -1.74% -3.35% -28.10% -201.83% -62.91% -1.19% -3.42% ROCE 12.33% 9.24% 41.28% 0.87% 2.72% 6.93% -16.09% -9.86% 6.98% 9.11% Fixed Asset Turnover 1.65 1.74 1.51 0.96 1.03 1.01 1.36 1.08 1.26 1.31 Receivable days 90.45 92.53 90.49 118.40 87.75 74.80 57.30 72.70 64.08 63.08 Inventory Days 63.56 61.85 56.34 78.37 65.41 73.58 71.75 82.12 68.11 69.36 Payable days 80.87 75.36 77.04 104.11 77.28 87.31 115.68 149.32 123.09 94.20 Cash Conversion Cycle 73.14 79.02 69.78 92.66 75.87 61.07 13.36 5.51 9.10 38.25 Total Debt/Equity 0.45 0.47 0.48 0.43 0.34 8.26 15.86 3.74 2.19 1.54 Interest Cover 3.63 2.80 12.19 0.41 0.64 0.81 -1.82 -1.18 0.82 1.15

Top Investors:

infinity holdings

unit trust of india investment advisory services limited a/c ascent india fund iii

sbi healthcare opportunities fund

ashoka india opportunities fund

Annual Reports:

News Update:

SeQuent Scientific gets ‘Certificate of Suitability’ approval for Diclazuril API
28th Jan 2021, 16:20 PM

Diclazuril is an antiprotozoal drug and is a preferred drug of choice for treating coccidiosis in livestock due to zero-day withdrawal period
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback